Analyze Diet
PloS one2024; 19(11); e0313783; doi: 10.1371/journal.pone.0313783

Treatment approaches to horses with acute diarrhea admitted to referral institutions: A multicenter retrospective study.

Abstract: This study aimed to describe and compare therapeutic approaches for horses with acute diarrhea in different geographic regions worldwide. Methods: Clinical information was retrospectively collected from diarrheic horses presented to participating institutions between 2016 and 2020, including fluid therapy on admission, antimicrobial drugs, probiotics, anti-endotoxic medications, anti-inflammatory drugs, gastroprotectants, digital cryotherapy, and toxin-binding agents. Seasonal and geographic differences were investigated. Results: 1438 horses from 26 participating hospitals from 5 continents were included. On admission, 65% (926/1419) of horses were administered a fluid bolus. Antimicrobial drugs were administered to 55% (792/1419) within the first 24 hours of admission, with penicillin and gentamicin being the most used combination (25%, 198/792). Horses with leukopenia (OR: 2.264, 95%CI: 1.754 to 2.921; P<0.001) or meeting systemic inflammatory response syndrome criteria (OR: 2.542, 95%CI: 1.919 to 3.368; P<0.001) had higher odds of being administered antimicrobial drugs. Other treatments administered included probiotics (15%, 215/1438), polymyxin B (13%; 187/1438), pentoxifylline (8%; 118/1438), gastroprotectants (44%; 626/1419), digital cryotherapy (34%; 489/1435), plasma transfusion (13%; 182/1410) and toxin-binding agents (36%; 515/1438). Conclusions: Due to the retrospective nature of the study, the rationale for treatment decisions was unavailable, and associations with survival could not be evaluated. Conclusions: Treatments varied between hospitals from different geographic regions. Prospective clinical trials are required to evaluate the effects of various treatments on survival.
Publication Date: 2024-11-20 PubMed ID: 39565809PubMed Central: PMC11578493DOI: 10.1371/journal.pone.0313783Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Multicenter Study

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study aims to understand and compare the treatment methods used for horses with acute diarrhea across different geographical regions worldwide. The treatments included fluid therapy, antimicrobial drugs, probiotics, anti-endotoxic medications, anti-inflammatory drugs, and other measures. It concluded with the understanding of variation in treatment methods but due to its retrospective nature, couldn’t assess the success rate of the treatments.

Methods

  • The researchers retrospectively gathered clinical data from horses with diarrhea admitted to participating hospitals worldwide from 2016 to 2020.
  • The treatments noted included fluid therapy upon admission, use of antimicrobial drugs, probiotics, anti-endotoxic medications, anti-inflammatory drugs, gastroprotectants, digital cryotherapy, and toxin-binding agents.
  • The study also focused on exploring seasonal and geographical differences in the above-mentioned treatment approaches.

Results

  • The study included data from 1438 horses admitted to 26 participating hospitals from five different continents.
  • In terms of fluid therapy, 65% of horses were administered a fluid bolus upon admission.
  • For antimicrobial drugs, 55% of the horses were given these drugs within the first 24 hours of admission with Penicillin and Gentamicin being the most commonly used drugs.
  • Other treatments included probiotics, polymyxin B, pentoxifylline, gastroprotectants, digital cryotherapy, plasma transfusion, and toxin-binding agents in varying proportions.
  • It was found horses with leukopenia or meeting systemic inflammatory response syndrome criteria had higher odds of being administered antimicrobial drugs.

Conclusions

  • Due to the retrospective nature of the study, it couldn’t provide reasonings behind different treatment decisions and associations with survival couldn’t be evaluated.
  • However, it was concluded that treatments varied between hospitals from different geographic regions.
  • Future prospective clinical trials are suggested by the study to evaluate the effects of these varied treatments on horse survival rates.

Cite This Article

APA
Gomez DE, Kopper JJ, Byrne DP, Renaud DL, Schoster A, Dunkel B, Arroyo LG, Mykkanen A, Gilsenan WF, Pihl TH, Lopez-Navarro G, Tennent-Brown BS, Hostnik LD, Mora-Pereira M, Marques F, Gold JR, DeNotta SL, Desjardins I, Stewart AJ, Kuroda T, Schaefer E, Oliver-Espinosa OJ, Agne GF, Uberti B, Veiras P, Delph Miller KM, Gialleti R, John E, Toribio RE. (2024). Treatment approaches to horses with acute diarrhea admitted to referral institutions: A multicenter retrospective study. PLoS One, 19(11), e0313783. https://doi.org/10.1371/journal.pone.0313783

Publication

ISSN: 1932-6203
NlmUniqueID: 101285081
Country: United States
Language: English
Volume: 19
Issue: 11
Pages: e0313783
PII: e0313783

Researcher Affiliations

Gomez, Diego E
  • Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada.
Kopper, Jamie J
  • Department of Veterinary Clinical Sciences, Iowa State University College of Veterinary Medicine, Ames, Iowa, United States of America.
Byrne, David P
  • School of Veterinary Medicine, Murdoch University, Perth, WA, Australia.
Renaud, David L
  • Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada.
Schoster, Angelika
  • Vetsuisse Faculty, Equine Department University of Zurich, Zurich, Switzerland.
  • Ludwig-Maximilians-University Munich, Equine Clinic, Oberschleissheim, Germany.
Dunkel, Bettina
  • Department of Clinical Science and Services, The Royal Veterinary College, Hertfordshire, United Kingdom.
Arroyo, Luis G
  • Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada.
Mykkanen, Anna
  • Department of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland.
Gilsenan, William F
  • Rood and Riddle Equine Hospital, Lexington, KY, United States of America.
Pihl, Tina H
  • Department of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Taastrup, Denmark.
Lopez-Navarro, Gabriela
  • Departamento de Medicina, Cirugía y Zootecnia Equina, Facultad de Medicina Veterinaria y de Zootecnia, Universidad Nacional Autonoma de Mexico, Ciudad de Mexico, Mexico.
Tennent-Brown, Brett S
  • U-Vet Werribee Animal Hospital and Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Werribee, Victoria, Australia.
Hostnik, Laura D
  • College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, United States of America.
Mora-Pereira, Mariano
  • Department of Clinical Sciences, College of Veterinary Medicine, Auburn University, Auburn, AL, United States of America.
Marques, Fernando
  • Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, United States of America.
Gold, Jenifer R
  • Department of Veterinary Clinical Sciences, Washington State University, Pullman, WA, United States of America.
  • Wisconsin Equine Clinic and Hospital, Oconomowoc, WI, United States of America.
DeNotta, Sally L
  • Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL, United States of America.
Desjardins, Isabelle
  • University of Lyon, VetAgro Sup, GREMERES-ICE Lyon Equine Research Center, Marcy l'Etoile, France.
Stewart, Allison J
  • School of Veterinary Science, The University of Queensland, Gatton, Queensland, Australia.
Kuroda, Taisuke
  • Clinical Veterinary Medicine Division, Equine Research Institute, Japan Racing Association, Shimotsuke, Tochigi, Japan.
Schaefer, Emily
  • Department of Large Animal Clinical Sciences, Marion duPont Scott Equine Medical Center, Leesburg, VA, United States of America.
Oliver-Espinosa, Olimpo J
  • Clinica de Grandes Animales, Departamento de Salud Animal, Facultad de Medicina Veterinaria y de Zootecnia, Universidad Nacional de Bogota de Santa Fe, Bogota, Colombia.
Agne, Gustavo Ferlini
  • School of Animal and Veterinary Science, Roseworthy Campus, The University of Adelaide, South Australia, Australia.
Uberti, Benjamin
  • Instituto de Ciencias Clinicas Veterinarias, Facultad de Ciencias Veterinarias, Universidad Austral de Chile, Valdivia, Chile.
  • Equine Veterinary Medical Center, Qatar Foundation, Doha, Qatar.
Veiras, Pablo
  • Fethard Equine Hospital, Fethard, Tipperary, Ireland.
Delph Miller, Katie M
  • Department of Clinical Sciences, Kansas State University, College of Veterinary Medicine, Manhattan, KS, United States of America.
Gialleti, Rodolfo
  • Centro di Ricerca del Cavallo Sportivo, Department of Veterinary Medicine, University of Perugia, Perugia, Italy.
John, Emily
  • Department of Health Management, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, PE, United States of America.
Toribio, Ramiro E
  • College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, United States of America.

MeSH Terms

  • Horses
  • Animals
  • Retrospective Studies
  • Horse Diseases / drug therapy
  • Horse Diseases / therapy
  • Diarrhea / drug therapy
  • Diarrhea / veterinary
  • Diarrhea / therapy
  • Male
  • Female
  • Acute Disease
  • Probiotics / therapeutic use
  • Fluid Therapy / methods
  • Anti-Bacterial Agents / therapeutic use
  • Referral and Consultation

Conflict of Interest Statement

The authors have declared that no competing interests exist.

References

This article includes 68 references
  1. Gomez DE, Leclere M, Arroyo LG, Li L, John E, Afonso T. Acute diarrhea in horses: A multicenter Canadian retrospective study (2015 to 2019). Can Vet J 2022 Oct;63(10):1033–1042.
    pmc: PMC9484212pubmed: 36185796
  2. Gomez DE, Arroyo LG, Stämpfli HR, Cruz LE, Oliver OJ. Physicochemical interpretation of acid-base abnormalities in 54 adult horses with acute severe colitis and diarrhea. J Vet Intern Med 2013 May-Jun;27(3):548–53.
    doi: 10.1111/jvim.12071pubmed: 23551698google scholar: lookup
  3. Cohen ND, Woods AM. Characteristics and risk factors for failure of horses with acute diarrhea to survive: 122 cases (1990–1996). J Am Vet Med Assoc 1999 Feb;214(3):382–90.
    pubmed: 10023402
  4. Luethy D, Feldman R, Stefanovski D, Aitken MR. Risk factors for laminitis and nonsurvival in acute colitis: Retrospective study of 85 hospitalized horses (2011–2019). J Vet Intern Med 2021;35:2019–25.
    doi: 10.1111/jvim.16147pmc: PMC8295695pubmed: 33938584google scholar: lookup
  5. Kullmann A, Holcombe SJ, Hurcombe SD, Roessner HA, Hauptman JG, Geor RJ. Prophylactic digital cryotherapy is associated with decreased incidence of laminitis in horses diagnosed with colitis. Equine Vet J 2014 Sep;46(5):554–9.
    doi: 10.1111/evj.12156pubmed: 23927380google scholar: lookup
  6. Stewart MC, Hodgson JL, Kim H, Hutchins DR, Hodgson DR. Acute febrile diarrhoea in horses: 86 cases (1986–1991). Aust Vet J 1995 Feb;72(2):41–4.
  7. Macías-Rioseco M, Hill AE, Uzal FA. Fatal intestinal inflammatory lesions in equids in California: 710 cases (1990–2013). J Am Vet Med Assoc 2020 Feb;256(4):455–62.
    doi: 10.2460/javma.256.4.455pubmed: 31999521google scholar: lookup
  8. Staempfli HR, Townsend HG, Prescott JF. Prognostic features and clinical presentation of acute idiopathic enterocolitis in horses. Can Vet J 1991 Apr;32(4):232–7.
    pmc: PMC1481315pubmed: 17423769
  9. Jones SL, Fecteau G, Hullinger PJ, Bickett-Weddle DA, St. Jean G, Nichols S. Diseases of the Alimentary Tract. Large Animal Internal Medicine 2019;(2019):702–920.e35.
  10. Gomez DE, Dunkel B, Renaud DL, Arroyo LG, Schoster A, Kopper JJ. Survival rates and factors associated with survival and laminitis of horses with acute diarrhoea admitted to referral institutions. Equine Vet J 2024 Sep;56(5):970–981.
    doi: 10.1111/evj.14032pubmed: 38083907google scholar: lookup
  11. Gomez DE, Arroyo LG, Schoster A, Renaud DL, Kopper JJ, Dunkel B. Diagnostic approaches, aetiological agents and their associations with short-term survival and laminitis in horses with acute diarrhoea admitted to referral institutions. Equine Vet J 2024 Sep;56(5):959–969.
    doi: 10.1111/evj.14024pubmed: 37984355google scholar: lookup
  12. Roy MF, Kwong GPS, Lambert J, Massie S, Lockhart S. Prognostic Value and Development of a Scoring System in Horses With Systemic Inflammatory Response Syndrome. J Vet Intern Med 2017 Mar;31(2):582–92.
    doi: 10.1111/jvim.14670pmc: PMC5354005pubmed: 28207163google scholar: lookup
  13. Tavanaeimanesh H, Dezfouli MRM, Vajhi A, Rostam A, Akbarinejad V, Sadeghian Chaleshtori S. The effect of 7.2% hypertonic saline solution on echocardiographic parameters of healthy horses. Equine Vet J 2015 Nov;47(6):741–4.
    doi: 10.1111/evj.12496pubmed: 26278206google scholar: lookup
  14. Schnuelle ML, Hopster K, Toribio RE, Hurcombe SD. Effects of 7.2% hypertonic saline solution on cardiovascular parameters and endogenous arginine vasopressin secretion in euvolemic isoflurane-anesthetized horses. Am J Vet Res 2022 Jul;83(9).
    doi: 10.2460/ajvr.21.08.0133pubmed: 35895759google scholar: lookup
  15. Dugdale AHA, Barron KE, Miller AJ, Proudman CJ. Effects of preoperative administration of hypertonic saline or pentastarch solution on hematologic variables and long-term survival of surgically managed horses with colic. J Am Vet Med Assoc 2015 May;246(10):1104–11.
    doi: 10.2460/javma.246.10.1104pubmed: 25932936google scholar: lookup
  16. Hallowell GD, Corley KTT. Preoperative administration of hydroxyethyl starch or hypertonic saline to horses with colic. J Vet Intern Med 2006;20(4):980–6.
  17. Matsushita FY, Krebs VLJ, de Carvalho WB. Association between fluid overload and mortality in newborns: a systematic review and meta-analysis. Pediatr Nephrol 2022 May;37(5):983–92.
    doi: 10.1007/s00467-021-05281-8pubmed: 34727245google scholar: lookup
  18. Zhang L, Chen Z, Diao Y, Yang Y, Fu P. Associations of fluid overload with mortality and kidney recovery in patients with acute kidney injury: A systematic review and meta-analysis. J Crit Care 2015 Aug;30(4):860.e7-13.
    doi: 10.1016/j.jcrc.2015.03.025pubmed: 25979272google scholar: lookup
  19. Giusto G, Vercelli C, Gandini M. Comparison of liberal and goal-directed fluid therapy after small intestinal surgery for strangulating lesions in horses. Vet Rec 2021 Feb;188(3):e5.
    doi: 10.1002/vetr.5pubmed: 34651880google scholar: lookup
  20. Hoaglund EL, Hess AM, Hassel DM. Retrospective evaluation of the effect of intravenous fluid administration on development of postoperative reflux in horses with colic (2004–2012): 194 horses. J Vet Emerg Crit Care (San Antonio) 2018 Nov;28(6):566–72.
    doi: 10.1111/vec.12776pubmed: 30302921google scholar: lookup
  21. Yue J, Zheng R, Wei H, Li J, Wu J, Wang P. Childhood Mortality After Fluid Bolus With Septic or Severe Infection Shock: A Systematic Review and Meta-Analysis. Shock 2021 Aug;56(2):158–66.
    doi: 10.1097/SHK.0000000000001657pubmed: 32881758google scholar: lookup
  22. Ukor IF, Hilton AK, Bailey MJ, Bellomo R. The haemodynamic effects of bolus versus slower infusion of intravenous crystalloid in healthy volunteers. J Crit Care 2017 Oct;41:254–9.
    doi: 10.1016/j.jcrc.2017.05.036pubmed: 28599199google scholar: lookup
  23. Loughran CM, Raisis AL, Hosgood G, Secombe CJ, Lester GD. The effect of dobutamine and bolus crystalloid fluids on the cardiovascular function of isoflurane-anaesthetised horses. Equine Vet J 2017 May;49(3):369–74.
    doi: 10.1111/evj.12605pubmed: 27350566google scholar: lookup
  24. Antequera Martín AM, Barea Mendoza JA, Muriel A, Sáez I, Chico-Fernández M, Estrada-Lorenzo JM. Buffered solutions versus 0.9% saline for resuscitation in critically ill adults and children. Cochrane Database Syst Rev 2019 Jul;7(7):CD012247.
  25. Jones PA, Bain FT, Byars TD, David JB, Boston RC. Effect of hydroxyethyl starch infusion on colloid oncotic pressure in hypoproteinemic horses. J Am Vet Med Assoc 2001 Apr;218(7):1130–5.
    doi: 10.2460/javma.2001.218.1130pubmed: 11318365google scholar: lookup
  26. Gratwick Z, Viljoen A, Page PC, Goddard A, Fosgate GT, Lyle CH. A comparison of the effects of a 4% modified fluid gelatin and a 6% hydroxyethyl starch on haemodilution, colloid osmotic pressure, haemostasis and renal parameters in healthy ponies. Equine Vet J 2017 May;49(3):363–8.
    doi: 10.1111/evj.12594pubmed: 27258662google scholar: lookup
  27. Wendt-Hornickle EL, Snyder LBC, Tang R, Johnson RA. The effects of lactated Ringer’s solution (LRS) or LRS and 6% hetastarch on the colloid osmotic pressure, total protein and osmolality in healthy horses under general anesthesia. Vet Anaesth Analg 2011 Jul;38(4):336–43.
  28. Pantaleon LG, Furr MO, McKenzie HC 2nd, Donaldson L. Cardiovascular and pulmonary effects of hetastarch plus hypertonic saline solutions during experimental endotoxemia in anesthetized horses. J Vet Intern Med 2006;20(6):1422–8.
    pubmed: 17186860
  29. Kopper JJ, Kogan CJ, Cook VL, Schott HC 2nd. Outcome of horses with enterocolitis receiving oncotic fluid support with either plasma or hetastarch. Can Vet J 2019 Nov;60(11):1207–12.
    pmc: PMC6805053pubmed: 31692633
  30. Viljoen A, Page PC, Fosgate GT, Saulez MN. Coagulation, oncotic and haemodilutional effects of a third-generation hydroxyethyl starch (130/0.4) solution in horses. Equine Vet J 2014 Nov;46(6):739–44.
    doi: 10.1111/evj.12223pubmed: 24372968google scholar: lookup
  31. Schusser GF, Rieckhoff K, Ungemach FR, Huskamp NH, Scheidemann W. Effect of hydroxyethyl starch solution in normal horses and horses with colic or acute colitis. J Vet Med A Physiol Pathol Clin Med 2007 Dec;54(10):592–8.
  32. McKenzie EC, Esser MM, McNitt SE, Payton ME. Effect of infusion of equine plasma or 6% hydroxyethyl starch (600/0.75) solution on plasma colloid osmotic pressure in healthy horses. Am J Vet Res 2016 Jul;77(7):708–14.
    doi: 10.2460/ajvr.77.7.708pubmed: 27347823google scholar: lookup
  33. Hepworth-Warren KL, Wong DM, Hay-Kraus BL, Wang C, Sun Y. Effects of administration of a synthetic low molecular weight/low molar substitution hydroxyethyl starch solution in healthy neonatal foals. Can Vet J 2015 Oct;56(10):1069–74.
    pmc: PMC4572826pubmed: 26483583
  34. Arroyo LG, Sears W, Gomez DE. Plasma transfusions in horses with typhlocolitis/colitis. Can Vet J 2019 Feb;60(2):193–6.
    pmc: PMC6340250pubmed: 30705457
  35. Vincent JL. Relevance of albumin in modern critical care medicine. Best Pract Res Clin Anaesthesiol 2009 Jun;23(2):183–91.
    doi: 10.1016/j.bpa.2008.11.004pubmed: 19653438google scholar: lookup
  36. Dunkel B. Science-in-brief: The role of the glycocalyx in critically ill patients with reference to the horse. Equine veterinary journal 2020;52:790–3.
    pubmed: 32786127
  37. Quinlan GJ, Margarson MP, Mumby S, Evans TW, Gutteridge JM. Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion. Clin Sci (Lond) 1998 Oct;95(4):459–65.
    pubmed: 9748422
  38. Jürgens G, Müller M, Garidel P, Koch MHJ, Nakakubo H, Blume A. Investigation into the interaction of recombinant human serum albumin with Re-lipopolysaccharide and lipid A. J Endotoxin Res 2002;8(2):115–26.
    doi: 10.1179/096805102125000263pubmed: 12028751google scholar: lookup
  39. Shaw SD, Stämpfli H. Diagnosis and Treatment of Undifferentiated and Infectious Acute Diarrhea in the Adult Horse. Vet Clin North Am Equine Pract 2018 Apr;34(1):39–53.
    doi: 10.1016/j.cveq.2017.11.002pmc: PMC7134835pubmed: 29426709google scholar: lookup
  40. Khusro A, Aarti C, Buendía-Rodriguez G, Arasu MV, Al-Dhabi NA, Barbabosa-Pliego A. Adverse Effect of Antibiotics Administration on Horse Health: An Overview. J Equine Vet Sci 2021 Feb;97:103339.
    doi: 10.1016/j.jevs.2020.103339pubmed: 33478757google scholar: lookup
  41. van Spijk JN, Beckmann K, Wehrli Eser M, Boxler M, Stirn M, Rhyner T. Adverse effects of polymyxin B administration to healthy horses. J Vet Intern Med 2022 Jul 1;36(4):1525–34.
    doi: 10.1111/jvim.16470pmc: PMC9308405pubmed: 35801274google scholar: lookup
  42. Dunkel B, Johns IC. Antimicrobial use in critically ill horses. J Vet Emerg Crit Care (San Antonio) 2015;25(1):89–100.
    doi: 10.1111/vec.12275pubmed: 25582245google scholar: lookup
  43. Arroyo LG, Moore A, Bedford S, Gomez DE, Teymournejad O, Xiong Q. Potomac horse fever in Ontario: Clinical, geographic, and diagnostic aspects. Can Vet J 2021 Jun;62(6):622–8.
    pmc: PMC8118184pubmed: 34219771
  44. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014 Aug;11(8):506–14.
    doi: 10.1038/nrgastro.2014.66pubmed: 24912386google scholar: lookup
  45. Berreta A, Burbick CR, Alexander T, Kogan C, Kopper JJ. Microbial Variability of Commercial Equine Probiotics. J Equine Vet Sci 2021 Nov;106:103728.
    doi: 10.1016/j.jevs.2021.103728pubmed: 34670695google scholar: lookup
  46. Weese JS, Martin H. Assessment of commercial probiotic bacterial contents and label accuracy. Can Vet J 2011 Jan;52(1):43–6.
    pmc: PMC3003573pubmed: 21461205
  47. Weese JS. Microbiologic evaluation of commercial probiotics. J Am Vet Med Assoc 2002 Mar;220(6):794–7.
    doi: 10.2460/javma.2002.220.794pubmed: 11918274google scholar: lookup
  48. Baumgardner RM, Berreta A, Kopper JJ. Evaluation of commercial probiotics for antimicrobial resistance genes. Can Vet J 2021 Apr;62(4):379–83.
    pmc: PMC7953935pubmed: 33867550
  49. Ströbel C, Günther E, Romanowski K, Büsing K, Urubschurov V, Zeyner A. Effects of oral supplementation of probiotic strains of Lactobacillus rhamnosus and Enterococcus faecium on diarrhoea events of foals in their first weeks of life. J Anim Physiol Anim Nutr (Berl) 2018 Oct 1;102(5):1357–65.
    doi: 10.1111/jpn.12923pubmed: 29790614google scholar: lookup
  50. Schoster A, Staempfli HR, Abrahams M, Jalali M, Weese JS, Guardabassi L. Effect of a probiotic on prevention of diarrhea and Clostridium difficile and Clostridium perfringens shedding in foals. J Vet Intern Med 2015;29(3):925–31.
    doi: 10.1111/jvim.12584pmc: PMC4895414pubmed: 25903509google scholar: lookup
  51. Weese JS, Rousseau J. Evaluation of Lactobacillus pentosus WE7 for prevention of diarrhea in neonatal foals. J Am Vet Med Assoc 2005 Jun;226(12):2031–4.
    doi: 10.2460/javma.2005.226.2031pubmed: 15989186google scholar: lookup
  52. Berreta A, Kopper J. Equine Probiotics-What Are They, Where Are We and Where Do We Need To Go?. J Equine Vet Sci 2022 Aug;115:104037.
    doi: 10.1016/j.jevs.2022.104037pubmed: 35688301google scholar: lookup
  53. Desrochers AM, Dolente BA, Roy MF, Boston R, Carlisle S. Efficacy of Saccharomyces boulardii for treatment of horses with acute enterocolitis. J Am Vet Med Assoc 2005 Sep;227(6):954–9.
    doi: 10.2460/javma.2005.227.954pubmed: 16190596google scholar: lookup
  54. Parviainen AK, Barton MH, Norton NN. Evaluation of polymyxin B in an ex vivo model of endotoxemia in horses. Am J Vet Res 2001 Jan;62(1):72–6.
    doi: 10.2460/ajvr.2001.62.72pubmed: 11197565google scholar: lookup
  55. Barton MH, Parviainen A, Norton N. Polymyxin B protects horses against induced endotoxaemia in vivo. Equine Vet J 2004 Jul;36(5):397–401.
    doi: 10.2746/0425164044868350pubmed: 15253079google scholar: lookup
  56. Cruz DN, Perazella MA, Bellomo R, de Cal M, Polanco N, Corradi V. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care 2007;11(2):R47.
    doi: 10.1186/cc5780pmc: PMC2206475pubmed: 17448226google scholar: lookup
  57. Payen DM, Guilhot J, Launey Y, Lukaszewicz AC, Kaaki M, Veber B. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med 2015 Jun;41(6):975–84.
    doi: 10.1007/s00134-015-3751-zpmc: PMC4477725pubmed: 25862039google scholar: lookup
  58. Antonelli M, Ronco C. Polymyxin B hemoperfusion in sepsis: growing body of evidence and occasional conflicting results. Blood purification 2015;39:I–II.
    doi: 10.1159/000431018pubmed: 25998615google scholar: lookup
  59. Barton MH, Moore JN. Pentoxifylline inhibits mediator synthesis in an equine in vitro whole blood model of endotoxemia. Circ Shock 1994 Dec;44(4):216–20.
    pubmed: 7628064
  60. Barton MH, Moore JN, Norton N. Effects of pentoxifylline infusion on response of horses to in vivo challenge exposure with endotoxin. Am J Vet Res 1997 Nov;58(11):1300–7.
    pubmed: 9361896
  61. Baskett A, Barton MH, Norton N, Anders B, Moore JN. Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses. Am J Vet Res 1997 Nov;58(11):1291–9.
    pubmed: 9361895
  62. Nakamae Y, Hobbs KJ, Ziegler J, Rivero LA, Kennedy S, Stockler J. Gastrointestinal foreign bodies in pet pigs: 17 cases. J Vet Intern Med 2022 May;36(3):1185–9.
    doi: 10.1111/jvim.16429pmc: PMC9151479pubmed: 35481711google scholar: lookup
  63. Tleyjeh IM, Bin Abdulhak AA, Riaz M, Alasmari FA, Garbati MA, AlGhamdi M. Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis. PLoS One 2012;7(12):e50836.
  64. Furr M, Cohen ND, Axon JE, Sanchez LC, Pantaleon L, Haggett E. Treatment with histamine-type 2 receptor antagonists and omeprazole increase the risk of diarrhoea in neonatal foals treated in intensive care units. Equine Vet J Suppl 2012 Feb;(41):80–6.
  65. Burke MJ, Tomlinson JE, Blikslager AT, Johnson AL, Dallap-Schaer BL. Evaluation of digital cryotherapy using a commercially available sleeve style ice boot in healthy horses and horses receiving i.v. endotoxin. Equine Vet J 2018 Nov;50(6):848–53.
    doi: 10.1111/evj.12842pubmed: 29654616google scholar: lookup
  66. van Eps AW, Pollitt CC, Underwood C, Medina-Torres CE, Goodwin WA, Belknap JK. Continuous digital hypothermia initiated after the onset of lameness prevents lamellar failure in the oligofructose laminitis model. Equine Vet J 2014 Sep;46(5):625–30.
    doi: 10.1111/evj.12180pubmed: 24004323google scholar: lookup
  67. Weese JS, Cote NM, deGannes RVG. Evaluation of in vitro properties of di-tri-octahedral smectite on clostridial toxins and growth. Equine Vet J 2003 Nov;35(7):638–41.
    doi: 10.2746/042516403775696384pubmed: 14649353google scholar: lookup
  68. Lawler JB, Hassel DM, Magnuson RJ, Hill AE, McCue PM, Traub-Dargatz JL. Adsorptive effects of di-tri-octahedral smectite on Clostridium perfringens alpha, beta, and beta-2 exotoxins and equine colostral antibodies. Am J Vet Res 2008 Feb;69(2):233–9.
    doi: 10.2460/ajvr.69.2.233pubmed: 18241021google scholar: lookup

Citations

This article has been cited 0 times.